# SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma

> **NCT01676792** · EARLY_PHASE1 · COMPLETED · sponsor: **National Cheng-Kung University Hospital** · enrollment: 29 (actual)

## Conditions studied

- Vulvar Intraepithelial Neoplasia
- Genital Warts

## Interventions

- **DRUG:** SR-T100 gel with 2.3% of SM in Solanum undatum plant extract

## Key facts

- **NCT ID:** NCT01676792
- **Lead sponsor:** National Cheng-Kung University Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2013-04
- **Final completion:** 2013-10
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2014-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01676792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01676792, "SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01676792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*